Figure 1
From: Poxvirus-based vaccine therapy for patients with advanced pancreatic cancer
Cellular immune responses in vaccinated patients. Peripheral blood mononuclear cells were collected at the indicated day (D) or month (M) following initial immunization. Peripheral blood mononuclear cells were co-cultured with CMMT 110/C1 cells infected with a multiplicity of infection (MOI) of 40 plaque-forming units (pfu)/cell of fowlpox virus expressing CEA, MUC-1 and TRICOM (Black), or fowlpox virus expressing PSA and TRICOM; (Grey). *Denotes two-fold increase of CEA/MUC-1-specific T cell response compared to PSA control.